1.
Journal of Association of Physicians of India
; 70(11):92-94, 2022.
Article
in English
| Scopus | ID: covidwho-2169735
2.
Journal of the Association of Physicians of India
; 70(January):14-17, 2022.
Article
in English
| GIM | ID: covidwho-1824219
ABSTRACT
Importance: As there is no definitive treatment available for covid-19 pneumonia, with timed administration of tocilizumab as an adjuvant therapy in moderate to severe covid-19 pneumonia, we can reduce mortality due to cytokine storm.